Streetbeat News

CDRO

Codere Online Luxembourg, S.A.

https://www.codereonline.com

Industry

Gambling, Resorts & Casinos

Codere Online Luxembourg, S.A. operates as an online casino gaming and sports betting company. The company also offers online casino wagering products and services. It primarily operates in Spain, Italy, Mexico, Colombia, Panama, and Argentina. The company is based in Luxembourg, Luxembourg.

Open

N/A

Mkt cap

N/A

Volume

N/A

High

N/A

P/E Ratio

N/A

52-wk high

N/A

Low

N/A

Div yield

N/A

52-wk low

N/A

U.S. stocks were mixed on Friday, with the Dow Jones index gaining around 50 points. Notable stock movements included Asana's 13.4% rise following a $150 million share repurchase program, Sarepta Therapeutics' 39.2% jump after FDA approval, and Clover Health's 31% gain due to insider buying. Other significant gainers included Hertz Global, Avid Bioservices, Cabaletta Bio, ADTRAN Holdings, Studio City International, Codere Online Luxembourg, Methode Electronics, Ironwood Pharmaceuticals, Enviri Corporation, PTC Therapeutics, and Spirit AeroSystems.

Portfolio Pulse from Avi Kapoor

June 21, 2024 | 2:45 pm

Codere Online Luxembourg has received a late-filing notice from Nasdaq, indicating a delay in submitting its financial report.

Portfolio Pulse from Benzinga Newsdesk

May 21, 2024 | 8:10 pm

Codere Online Luxembourg shares are trading higher after Stifel maintained a Buy rating on the stock and raised its price target from $8 to $9.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 4:18 pm

The article highlights the pre-market movements of several consumer discretionary stocks on Thursday. Notable gainers include Faraday Future (FFIE), SRIVARU Holding (SVMH), Sonder Holdings (SOND), PetMed Express (PETS), Codere Online Luxembourg (CDRO), and Lixiang Education Hldg (LXEH). On the losing side, Selina Hospitality (SLNA), Sleep Number (SNBR), GameStop (GME), Under Armour (UAA, UA), and Serve Robotics (SERV) saw declines.

Portfolio Pulse from Benzinga Insights

May 16, 2024 | 12:07 pm

Stifel analyst Jeffrey Stantial maintains a Buy rating on Codere Online Luxembourg (NASDAQ:CDRO) and raises the price target from $8 to $9.

Portfolio Pulse from Benzinga Newsdesk

May 16, 2024 | 11:54 am

Bolt Biotherapeutics shares fell 34% after reporting a GAAP loss of 28 cents per share on $5.30 million in sales. Analysts from Guggenheim and Stifel downgraded the stock. Other stocks like AERWINS Technologies and Sintx Technologies saw significant gains, while Virpax Pharmaceuticals and Yield10 Bioscience experienced notable losses.

Portfolio Pulse from Avi Kapoor

May 15, 2024 | 5:38 pm

NEXTracker Inc. (NASDAQ:NXT) reported better-than-expected Q4 earnings, leading to a 7.7% rise in its stock price. Other notable gainers include monday.com Ltd. (NASDAQ:MNDY), BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX), and Nu Holdings Ltd. (NYSE:NU), among others.

Portfolio Pulse from Avi Kapoor

May 15, 2024 | 2:22 pm

As of March 8, 2024, Carvana Co. (CVNA), Codere Online Luxembourg, S.A. (CDRO), and CarMax, Inc. (KMX) in the consumer discretionary sector are considered overbought based on their RSI values, indicating potential short-term performance issues. CVNA and CDRO have seen significant stock gains over the past month, while KMX also showed growth but to a lesser extent.

Portfolio Pulse from Avi Kapoor

March 08, 2024 | 1:54 pm

Stifel analyst Jeffrey Stantial has maintained a Buy rating on Codere Online Luxembourg (CDRO) and increased the price target from $6 to $8.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:51 pm

Numerous companies are scheduled to report their earnings on February 29, 2024, covering a wide range of industries from technology to healthcare. This includes both expected quarterly profits and losses, with significant revenues anticipated for some. The diversity of sectors represented, from energy to financial services, highlights the broad economic implications of these reports.

Portfolio Pulse from Benzinga Insights

February 29, 2024 | 10:15 am

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.